Harnessing GenAI to Transform Clinical Development: Key Insights from SCOPE 2025
Feb 12, 2025🚀 The future of clinical development is being redefined with the power of Generative AI! 🌐 At SCOPE 2025, thousands of professionals gathered to explore how AI is transforming clinical trials—boosting efficiency, compliance, and human expertise. Key insights from top thought leaders highlighted AI's potential to streamline workflows and drive innovation. 🌟💡 Discover how platforms like AuroraPrime are revolutionizing medical writing and data integration, speeding up processes and ensuring compliance in minutes. 🌱 Let's dive into the groundbreaking ideas from SCOPE 2025! 🔍
It was an incredible experience to join the global community of clinical research and digital health experts at the SCOPE US 2025 Summit in Orlando, FL, where over 4,000 professionals from 30 countries gathered to explore the latest insights and innovations in clinical development.
A major highlight was the focus on Generative AI. From practical applications in clinical trials to holistic integration strategies, the sessions showcased how AI can enhance efficiency while addressing ethical and regulatory considerations. A noteworthy keynote panel—“The Unleashing of Gen AI: Revolutionizing Healthcare and Beyond”—featured thought leaders James Gallagh, Andrew Lee, Brian Martin, and Demetris Zambas, who shared insights on AI’s transformative role in clinical research. They explored how AI is reshaping workflows, scaling from proof-of-concept to enterprise adoption, and addressing regulatory challenges, AI governance, and the evolving role of human expertise—key considerations for innovative teams embracing AI’s potential.
Sharon Chen, our Founder and CEO, shared her expertise in the presentation “Generative AI-Powered Medical Writing Platform,” demonstrating how AuroraPrime accelerates document creation. Seamlessly integrating with Veeva RIM, AuroraPrime connects data sources across the clinical lifecycle—generating first drafts of study protocols and CSRs in minutes with consistency and compliance. Sharon also addressed audience questions on expanding supported document types, defining broad content structures, and facilitating content reuse, providing valuable insights into how AuroraPrime continues to evolve to meet industry needs.
AlphaLife Sciences is transforming clinical research with AuroraPrime, our GenAI-powered platform that streamlines workflows and accelerates timelines. Connect with us to learn more!
